Contrast-Induced Nephropathy: An "All or None" Phenomenon?

Area of Science:

• Nephrology
• Radiology
• Cardiology

Background:

• Contrast-induced nephropathy (CIN) is a serious adverse event linked to contrast media (CM) administration.
• CIN increases hospitalization duration, cardiovascular and renal morbidity, and overall mortality.
• Identifying high-risk patients is essential for effective CIN management.

Purpose of the Study:

• To review risk factors, diagnostic approaches, and prevention strategies for CIN.
• To highlight the importance of monitoring renal function post-CM administration, even in the absence of CIN.
• To emphasize the need for long-term patient follow-up after CM exposure.

Main Methods:

• Literature review of CIN risk factors, diagnostic biomarkers, and preventive measures.
• Analysis of the multifactorial approach to CIN prevention.
• Discussion on the spectrum of renal function changes after CM administration.

Main Results:

• Several risk factors and predictive scores for CIN incidence exist.
• Novel biomarkers may aid in earlier CIN diagnosis.
• A multifactorial approach including hydration, appropriate CM selection, minimized CM volume, and statins is recommended for prevention.

Conclusions:

• Renal function decline post-CM administration may occur even without overt CIN and is an underestimated risk.
• Long-term outpatient monitoring of kidney function after CM exposure is vital for predicting future morbidity and mortality.
• A comprehensive strategy involving risk assessment, prevention, and vigilant follow-up is necessary for managing CIN.